Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The immunoglobulin E (IgE)-mediated response is a specific type of immune reaction primarily involved in allergic diseases and defense against certain parasites. IgE is an antibody produced by plasma cells, a subset of B lymphocytes, in response to exposure to allergens or parasitic antigens. This response is central to the pathogenesis of immediate (Type I) hypersensitivity reactions, including allergic rhinitis, asthma, atopic dermatitis, food allergies, and anaphylaxis.
Drugs target various points in the pathway including: - Blocking histamine effects - Suppressing inflammation - Blocking leukotriene-mediated effects - Preventing mast cell degranulation - Sequestering free IgE or blocking its receptor interaction
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin E-mediated Response (IgE-mediated Response).